Ken Griffin Celcuity Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Celcuity Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 4,800 shares of CELC stock, worth $71,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,800
Previous 15,600
69.23%
Holding current value
$71,904
Previous $336,000
76.79%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CELC
# of Institutions
93Shares Held
30.1MCall Options Held
4.8KPut Options Held
126K-
Bvf Inc San Francisco, CA3.47MShares$51.9 Million1.74% of portfolio
-
Morgan Stanley New York, NY2.84MShares$42.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$35.4 Million1.12% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$28.1 Million0.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$23.5 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $224M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...